title: MN community measurement responds.
authors.forename: Jim
authors.initials: J
authors.lastname: Chase
authors.forename: Beth
authors.initials: B
authors.lastname: Averbeck
authors.forename: Linda
authors.initials: L
authors.lastname: Walling
authors.forename: Kaiser
authors.initials: K
authors.lastname: Lim
mesh_terms: D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D001249:Asthma / Q000628:therapy; D035843:Biomedical Research / Q000331:legislation & jurisprudence / Q000592:standards; D057186:Comparative Effectiveness Research / Q000331:legislation & jurisprudence*; D003661:Decision Support Techniques; D003925:Diabetic Angiopathies / Q000628:therapy; D019983:Guideline Adherence / Q000331:legislation & jurisprudence* / Q000592:standards*; D006801:Humans; D008910:Minnesota; D058996:Quality Improvement / Q000331:legislation & jurisprudence* / Q000592:standards*; D016032:Randomized Controlled Trials as Topic; D012052:Reimbursement, Incentive / Q000331:legislation & jurisprudence; D016896:Treatment Outcome; D014481:United States
chemical_list: D001241:Aspirin